Cargando…
(☆)Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (5), utility of bone scintigraphy and (18)F-FDG PET/CT in early detection and risk assessment of medication-related osteonecrosis of the jaw (secondary publication)
Medication-related osteonecrosis of the jaw (MRONJ) is a significant side effect of antiresorptive and antiangiogenic drugs. Since MRONJ is intractable, early detection is the best way to limit progression. Bone scintigraphy and (18)F- fluorodeoxyglucose positron-emission tomography can detect minim...
Autores principales: | Watanabe, Satoru, Nakajima, Kenichi, Kinuya, Seigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431786/ https://www.ncbi.nlm.nih.gov/pubmed/30956739 http://dx.doi.org/10.1016/j.jdsr.2018.12.002 |
Ejemplares similares
-
Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)()
por: Baba, Akira, et al.
Publicado: (2019) -
Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (1), role of imaging in drug-related osteonecrosis of the jaw: An up-to-date review (secondary publication)()
por: Tsuchimochi, Makoto, et al.
Publicado: (2019) -
Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw()
por: Kitagawa, Yoshimasa, et al.
Publicado: (2019) -
Bisphophonates related osteonecrosis of the jaw
por: Gupta, Swati, et al.
Publicado: (2013) -
Osteonecrosis of the Jaw
por: Lončar Brzak, Božana, et al.
Publicado: (2023)